Cefiderocol (antibiotic of last resort: infections caused by aerobic gram-negative pathogens)

Subject:

• Active Substance: Cefiderocol
• Name: Fetcroja^®
• Therapeutic area: Infections caused by aerobic gram-negative pathogens
• Pharmaceutical company: Shionogi GmbH

Time table:

• Start: 15.11.2021
• Final decision by G-BA: 05.05.2022

Final decision:

• Additional benefit proved (reserve antibiotic)